Donald E. Morel, Jr
2009
In 2009, Donald E. Morel, Jr earned a total compensation of $3.7M as Chairman of the Board and Chief Executive Officer at West Pharmaceutical Services, a 13% decrease compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $398,218 |
|---|---|
| Non-Equity Incentive Plan | $766,042 |
| Option Awards | $695,000 |
| Salary | $809,162 |
| Stock Awards | $994,790 |
| Other | $65,695 |
| Total | $3,728,907 |
Morel received $994.8K in stock awards, accounting for 27% of the total pay in 2009.
Morel also received $398.2K of change in pension value and nonqualified deferred compensation earnings, $766K in non-equity incentive plan, $695K in option awards, $809.2K in salary and $65.7K in other compensation.
Rankings
In 2009, Donald E. Morel, Jr's compensation ranked 1,139th out of 9,885 executives tracked by ExecPay. In other words, Morel earned more than 88.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,139 out of 9,885 | 89th |
Division Manufacturing | 404 out of 3,690 | 89th |
Major group Rubber And Miscellaneous Plastics Products | 8 out of 84 | 91st |
Industry group Fabricated Rubber Products, Not Elsewhere | 2 out of 21 | 91st |
Source: SEC filing on March 23, 2010.
Morel's colleagues
We found five more compensation records of executives who worked with Donald E. Morel, Jr at West Pharmaceutical Services in 2009.
2009
Steven Ellers
West Pharmaceutical Services
Chief Operating Officer
2009
Matthew Mullarkey
West Pharmaceutical Services
Chief Operating Officer
2009
William Federici
West Pharmaceutical Services
Chief Financial Officer
2009
John Gailey
West Pharmaceutical Services
General Counsel
2009
Heino Lennartz
West Pharmaceutical Services